NASDAQ:OPTH Optimi Health (OPTH) Stock Price, News & Analysis $4.36 +0.17 (+4.06%) As of 04:00 PM Eastern Add Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsSEC FilingsShort InterestTrendsBuy This Stock About Optimi Health Stock (NASDAQ:OPTH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Optimi Health alerts:Sign Up Key Stats Today's Range$4.01▼$4.4650-Day Range N/A52-Week Range$4.00▼$6.40Volume101,527 shsAverage Volume186,259 shsMarket Capitalization$24.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Read More Receive OPTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Optimi Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OPTH Stock News HeadlinesOptimi Health Launches Standardized Microdose Psilocybin Products for Clinical ResearchJune 16 at 8:30 AM | globenewswire.comOPTIMI HEALTH CORP.: Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical TrialJune 12, 2026 | finanznachrichten.deTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.June 17 at 1:00 AM | Porter & Company (Ad)Optimi Health Corp: Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical TrialJune 11, 2026 | finanznachrichten.deOptimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical TrialJune 10, 2026 | globenewswire.comOptimi Health CorpJune 8, 2026 | money.usnews.comOptimi Health Secures Ibogaine Supply and Commences Finished Drug Product DevelopmentJune 8, 2026 | globenewswire.comOptimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in AustraliaJune 2, 2026 | globenewswire.comSee More Headlines OPTH Stock Analysis - Frequently Asked Questions How have OPTH shares performed this year? Optimi Health's stock was trading at $6.08 at the start of the year. Since then, OPTH stock has decreased by 28.3% and is now trading at $4.36. How were Optimi Health's earnings last quarter? Optimi Health Corp. (NASDAQ:OPTH) posted its earnings results on Monday, June, 1st. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by $0.01. The business earned $0.07 million during the quarter. When did Optimi Health's stock split? Optimi Health shares reverse split on Wednesday, May 20th 2026.A 1-30 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 19th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did Optimi Health IPO? Optimi Health (OPTH) raised $15 million in an initial public offering (IPO) on Wednesday, May 20th 2026. The company issued 2,400,000 shares at $6.25 per share. Joseph Gunnar & Co. served as the underwriter for the IPO. When does the company's quiet period expire? Optimi Health's quiet period expires on Monday, June 29th. Optimi Health had issued 2,400,000 shares in its IPO on May 20th. The total size of the offering was $15,000,000 based on an initial share price of $6.25. During the company's quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company. How do I buy shares of Optimi Health? Shares of OPTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings6/01/2026Today6/17/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:OPTH CIK2027329 WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$231.86 thousand Price / Sales105.79 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares5,626,000Free FloatN/AMarket Cap$24.53 million OptionableN/A BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free Report This page (NASDAQ:OPTH) was last updated on 6/17/2026 by MarketBeat.com Staff. From Our PartnersIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Optimi Health Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Optimi Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.